
Colgate-Palmolive Company: shareholders and insiders
Price
$99.61
November 17, 2026Market cap $79.8B
What Ploutos Investor adds for Colgate-Palmolive
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 12, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$64M
9 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $64M by 9 people
- 2025: no buys, sold $100.1K by 1 person
- 2026: no buys, sold $64M by 9 people
- Nov 10, 2026Gregory MalcolmEVP and ControllerKind
- Nov 5, 2026Lorrie M NorringtonDirectorKind
- Nov 5, 2026Lorrie M NorringtonDirectorKind
- Nov 5, 2026Noel R. WallaceChairman, President & CEOKind
- Nov 4, 2026Panagiotis TsourapasCOO, CD, EMEA, APac, SkinKind
- Nov 4, 2026Panagiotis TsourapasCOO, CD, EMEA, APac, SkinKind
- Nov 4, 2026John HazlinChief Growth OfficerKind
- Nov 4, 2026John HazlinChief Growth OfficerKind
- Oct 1, 2026Lorrie M NorringtonDirectorKind
- Oct 1, 2026Brian NewmanDirectorKind
- Oct 1, 2026John P BilbreyDirectorKind
- Sep 16, 2026Noel R. WallaceChairman, President & CEOKind
- Sep 16, 2026Shane GrantCOO, AmericasKind
- Sep 16, 2026Panagiotis TsourapasCOO, CD, EMEA, APac, SkinKind
- Sep 16, 2026Stanley J Sutula IiiChief Financial OfficerKind
- Sep 16, 2026John HazlinChief Growth OfficerKind
- Sep 16, 2026Sally MasseyChief People OfficerKind
- Sep 16, 2026Betsy FishboneCLO and SecretaryKind
- Sep 16, 2026Gregory MalcolmEVP and ControllerKind
- Sep 13, 2026Noel R. WallaceChairman, President & CEOKind
- Sep 13, 2026Panagiotis TsourapasCOO, CD, EMEA, APac, SkinKind
- Sep 13, 2026Stanley J Sutula IiiChief Financial OfficerKind
- Sep 13, 2026Sally MasseyChief People OfficerKind
- Sep 13, 2026Gregory MalcolmEVP and ControllerKind
- Sep 13, 2026John HazlinChief Growth OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Gregory MalcolmEVP and Controller | 4,100 | $97.97 | $401.7K | Form 4 | |
| Nov 5, 2026 | Lorrie M NorringtonDirector | 4,170 | $71.56 | $298.4K | Form 4 | |
| Nov 5, 2026 | Lorrie M NorringtonDirector | 4,170 | $99.31 | $414.1K | Form 4 | |
| Nov 5, 2026 | Noel R. WallaceChairman, President & CEO | 20.0K | $100.26 | $2.0M | Form 4 | |
| Nov 4, 2026 | Panagiotis TsourapasCOO, CD, EMEA, APac, Skin | 19.9K | $76.41 | $1.5M | Form 4 | |
| Nov 4, 2026 | Panagiotis TsourapasCOO, CD, EMEA, APac, Skin | 19.9K | $98.74 | $2.0M | Form 4 | |
| Nov 4, 2026 | John HazlinChief Growth Officer | 23.4K | $77.04 | $1.8M | Form 4 | |
| Nov 4, 2026 | John HazlinChief Growth Officer | 23.4K | $99.15 | $2.3M | Form 4 | |
| Oct 1, 2026 | Lorrie M NorringtonDirector | 300 | $87.42 | $26.2K | Form 4 | |
| Oct 1, 2026 | Brian NewmanDirector | 214 | $87.42 | $18.7K | Form 4 | |
| Oct 1, 2026 | John P BilbreyDirector | 271 | $87.42 | $23.7K | Form 4 | |
| Sep 16, 2026 | Noel R. WallaceChairman, President & CEO | 29.6K | – | – | Form 4 | |
| Sep 16, 2026 | Shane GrantCOO, Americas | 7,355 | – | – | Form 4 | |
| Sep 16, 2026 | Panagiotis TsourapasCOO, CD, EMEA, APac, Skin | 4,597 | – | – | Form 4 | |
| Sep 16, 2026 | Stanley J Sutula IiiChief Financial Officer | 8,045 | – | – | Form 4 | |
| Sep 16, 2026 | John HazlinChief Growth Officer | 3,908 | – | – | Form 4 | |
| Sep 16, 2026 | Sally MasseyChief People Officer | 3,333 | – | – | Form 4 | |
| Sep 16, 2026 | Betsy FishboneCLO and Secretary | 2,207 | – | – | Form 4 | |
| Sep 16, 2026 | Gregory MalcolmEVP and Controller | 1,081 | – | – | Form 4 | |
| Sep 13, 2026 | Noel R. WallaceChairman, President & CEO | 4,892 | $86.80 | $424.6K | Form 4 | |
| Sep 13, 2026 | Panagiotis TsourapasCOO, CD, EMEA, APac, Skin | 922 | $86.80 | $80.0K | Form 4 | |
| Sep 13, 2026 | Stanley J Sutula IiiChief Financial Officer | 1,385 | $86.80 | $120.2K | Form 4 | |
| Sep 13, 2026 | Sally MasseyChief People Officer | 686 | $86.80 | $59.5K | Form 4 | |
| Sep 13, 2026 | Gregory MalcolmEVP and Controller | 225 | $86.80 | $19.5K | Form 4 | |
| Sep 13, 2026 | John HazlinChief Growth Officer | 499 | $86.80 | $43.3K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 17, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by CL's officers and directors from 2006 up to November 17, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Vanguard Capital ManagementShare of class7.52%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.52% | 60.40M | Apr 29, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 26, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+44%
- Renaissance TechnologiesIn the quarter+86%
- AQR CapitalIn the quarter+162%
- Millennium Mgmt (Englander)In the quarter+72%
- Bridgewater (Dalio)In the quarter-8.8%
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter-67%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 4.58M | +44% | $420M | 0.24% |
| Renaissance Technologies | 1.64M | +86% | $140M | 0.19% |
| AQR Capital | 4.67M | +162% | $427M | 0.15% |
| Millennium Mgmt (Englander) | 1.28M | +72% | $117M | 0.08% |
| Bridgewater (Dalio) | 77.1K | -8.8% | $7.1M | 0.03% |
| Point72 (Cohen) | 70.1K | $6.4M | 0.01% | |
| D.E. Shaw | 157.9K | -67% | $15M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 2.17% of its shares outstanding were held short, -27.6% since the report before.
- Shares held short
- 17.41M
- 2.17%
- Since the report before24.04M on Sep 30, 2026
- -27.6%
- 3.5
- 4.93M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 42%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 9.32M
- Nov 15, 2023: Shares held short 11.61M
- Nov 30, 2023: Shares held short 10.90M
- Dec 15, 2023: Shares held short 10.87M
- Dec 29, 2023: Shares held short 9.84M
- Jan 12, 2024: Shares held short 9.70M
- Jan 31, 2024: Shares held short 10.09M
- Feb 15, 2024: Shares held short 11.13M
- Feb 29, 2024: Shares held short 11.91M
- Mar 15, 2024: Shares held short 11.66M
- Mar 28, 2024: Shares held short 11.75M
- Apr 15, 2024: Shares held short 9.42M
- Apr 30, 2024: Shares held short 10.65M
- May 15, 2024: Shares held short 10.23M
- May 31, 2024: Shares held short 7.43M
- Jun 14, 2024: Shares held short 9.90M
- Jun 28, 2024: Shares held short 10.35M
- Jul 15, 2024: Shares held short 8.93M
- Jul 31, 2024: Shares held short 8.91M
- Aug 15, 2024: Shares held short 8.17M
- Aug 30, 2024: Shares held short 8.70M
- Sep 13, 2024: Shares held short 8.48M
- Sep 30, 2024: Shares held short 10.20M
- Oct 15, 2024: Shares held short 10.31M
- Oct 31, 2024: Shares held short 10.42M
- Nov 15, 2024: Shares held short 11.20M
- Nov 29, 2024: Shares held short 8.91M
- Dec 13, 2024: Shares held short 9.29M
- Dec 31, 2024: Shares held short 9.24M
- Jan 15, 2025: Shares held short 10.08M
- Jan 31, 2025: Shares held short 9.56M
- Feb 14, 2025: Shares held short 9.04M
- Feb 28, 2025: Shares held short 10.72M
- Mar 14, 2025: Shares held short 10.67M
- Mar 31, 2025: Shares held short 11.04M
- Apr 15, 2025: Shares held short 11.46M
- Apr 30, 2025: Shares held short 12.02M
- May 15, 2025: Shares held short 12.13M
- May 30, 2025: Shares held short 11.51M
- Jun 13, 2025: Shares held short 11.82M
- Jun 30, 2025: Shares held short 12.07M
- Jul 15, 2025: Shares held short 13.54M
- Jul 31, 2025: Shares held short 11.80M
- Aug 15, 2025: Shares held short 12.03M
- Aug 29, 2025: Shares held short 11.61M
- Sep 15, 2025: Shares held short 12.61M
- Sep 30, 2025: Shares held short 13.90M
- Oct 15, 2025: Shares held short 15.40M
- Oct 31, 2025: Shares held short 13.71M
- Nov 14, 2025: Shares held short 14.26M
- Nov 28, 2025: Shares held short 14.30M
- Dec 15, 2025: Shares held short 13.52M
- Dec 31, 2025: Shares held short 14.45M
- Jan 15, 2026: Shares held short 16.34M
- Jan 30, 2026: Shares held short 15.27M
- Feb 13, 2026: Shares held short 16.59M
- Feb 27, 2026: Shares held short 19.54M
- Mar 13, 2026: Shares held short 20.34M
- Mar 31, 2026: Shares held short 21.36M
- Apr 15, 2026: Shares held short 19.41M
- Apr 30, 2026: Shares held short 17.25M
- May 15, 2026: Shares held short 19.84M
- May 29, 2026: Shares held short 21.14M
- Jun 15, 2026: Shares held short 20.53M
- Jun 30, 2026: Shares held short 17.53M
- Jul 15, 2026: Shares held short 16.72M
- Jul 31, 2026: Shares held short 17.77M
- Aug 14, 2026: Shares held short 17.56M
- Aug 31, 2026: Shares held short 17.17M
- Sep 15, 2026: Shares held short 18.40M
- Sep 30, 2026: Shares held short 24.04M
- Oct 15, 2026: Shares held short 17.41M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading48.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 48.5% of the shares in the reported trades were short sales, against 57.8% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 48.5%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 57.8%
- Change
- -9.3 pts
- Short sales a dayon average, of 1.88M shares
- 910.3K
- More than atof 3,666 US-listed companies, same days
- 43%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 49.5%
- Oct 12, 2026: Short sales 46.7%
- Oct 13, 2026: Short sales 59.8%
- Oct 14, 2026: Short sales 58.8%
- Oct 15, 2026: Short sales 61.5%
- Oct 16, 2026: Short sales 51.8%
- Oct 19, 2026: Short sales 60.9%
- Oct 20, 2026: Short sales 52.7%
- Oct 21, 2026: Short sales 58.7%
- Oct 22, 2026: Short sales 58.3%
- Oct 23, 2026: Short sales 63.1%
- Oct 26, 2026: Short sales 60%
- Oct 27, 2026: Short sales 67.6%
- Oct 28, 2026: Short sales 55.5%
- Oct 29, 2026: Short sales 51.5%
- Oct 30, 2026: Short sales 56.2%
- Nov 2, 2026: Short sales 59.2%
- Nov 3, 2026: Short sales 37.1%
- Nov 4, 2026: Short sales 44.9%
- Nov 5, 2026: Short sales 51.4%
- Nov 6, 2026: Short sales 38.1%
- Nov 9, 2026: Short sales 33.4%
- Nov 10, 2026: Short sales 57.5%
- Nov 11, 2026: Short sales 60.3%
- Nov 12, 2026: Short sales 58.7%
- Nov 13, 2026: Short sales 49.9%
- Nov 16, 2026: Short sales 43.9%
- Nov 17, 2026: Short sales 34.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Noel R. WallaceChairman, President & CEODirectly467.2K
- Panagiotis TsourapasCOO, CD, EMEA, APac, SkinDirectly16.1K
- Shane GrantCOO, AmericasDirectly79.5K
- Stanley J Sutula IiiChief Financial OfficerDirectly79.4K
- Jennifer DanielsCLO and SecretaryDirectly76.4K
- John P BilbreyDirectorDirectly45.4K
- Lorrie M NorringtonDirectorDirectly43.4K
- John HazlinChief Growth OfficerDirectly32.6K
- John T CahillDirectorDirectly28.4K
- Betsy FishboneCLO and SecretaryDirectly24.4K
- Sally MasseyChief People OfficerDirectly23.6K
- C Martin HarrisDirectorDirectly19.3K
- Gregory MalcolmEVP and ControllerDirectly18.8K
- Prabha ParameswaranGrp Pres, Growth & StrategyDirectly18.7K
- Martina HundmejeanDirectorDirectly11.8K
- Brian NewmanDirectorDirectly8,094
- John W KooymanChief of StaffDirectly3,191
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Noel R. WallaceChairman, President & CEO | 467.2K | – | Nov 5, 2026 | Form 4 |
| Panagiotis TsourapasCOO, CD, EMEA, APac, Skin | 16.1K | 64.9K | Nov 4, 2026 | Form 4 |
| Shane GrantCOO, Americas | 79.5K | – | Sep 16, 2026 | Form 4 |
| Stanley J Sutula IiiChief Financial Officer | 79.4K | – | Sep 16, 2026 | Form 4 |
| Jennifer DanielsCLO and Secretary | 76.4K | – | Feb 4, 2026 | Form 4 |
| John P BilbreyDirector | 45.4K | – | Oct 1, 2026 | Form 4 |
| Lorrie M NorringtonDirector | 43.4K | – | Nov 5, 2026 | Form 4 |
| John HazlinChief Growth Officer | 32.6K | – | Nov 4, 2026 | Form 4 |
| John T CahillDirector | 28.4K | – | Aug 6, 2026 | Form 4 |
| Betsy FishboneCLO and Secretary | 24.4K | – | Sep 16, 2026 | Form 4 |
| Sally MasseyChief People Officer | 23.6K | – | Sep 16, 2026 | Form 4 |
| C Martin HarrisDirector | 19.3K | – | Jan 31, 2024 | Form 4 |
| Gregory MalcolmEVP and Controller | 18.8K | – | Nov 10, 2026 | Form 4 |
| Prabha ParameswaranGrp Pres, Growth & Strategy | 18.7K | – | Feb 16, 2024 | Form 4 |
| Martina HundmejeanDirector | 11.8K | – | Aug 23, 2024 | Form 4 |
| Brian NewmanDirector | 8,094 | – | Oct 1, 2026 | Form 4 |
| John W KooymanChief of Staff | 3,191 | – | Aug 6, 2024 | Form 4 |
A lower bound: it counts only the 17 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Jennifer M. DanielsChief Legal Officer and SecretaryWhat happenedAdoptedMay 1, 2025Shares6,000
- Noel R. WallaceChairman, President and Chief ExecutiveWhat happenedAdoptedAug 21, 2024Shares100.0K
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Jennifer M. DanielsChief Legal Officer and Secretary | AdoptedMay 1, 2025 | Dec 5, 2025 | 6,000 | 10-Q |
| Noel R. WallaceChairman, President and Chief Executive | AdoptedAug 21, 2024 | May 23, 2025 | 100.0K | 10-Q |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$16M
Actually paid: $12M
$6.4M
Actually paid: $5.5M
$104
Peers: $112
Organic sales growth
From the proxy statement (DEF 14A) of Mar 25, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Jun 30, 202610-QAmount$282M
- Mar 31, 202610-QAmount$306M
- Dec 31, 202510-KAmount$400M
- Sep 30, 202510-QAmount$288M
- Jun 30, 202510-QAmount$232M
- Mar 31, 202510-QAmount$284M
- Dec 31, 202410-KAmount$453M
- Sep 30, 202410-QAmount$295M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Jun 30, 202610-Q | 3.22M | $87.40 | $282M | $3.5B | 10-Q |
| Mar 31, 202610-Q | 3.39M | $90.28 | $306M | $3.8B | 10-Q |
| Dec 31, 202510-K | 5.09M | $78.54 | $400M | $4.1B | 10-K |
| Sep 30, 202510-Q | 3.41M | $84.47 | $288M | $4.5B | 10-Q |
| Jun 30, 202510-Q | 2.56M | $90.65 | $232M | $4.7B | 10-Q |
| Mar 31, 202510-Q | 3.18M | $89.04 | $284M | $5.0B | 10-Q |
| Dec 31, 202410-K | 4.80M | $94.55 | $453M | $1.2B | 10-K |
| Sep 30, 202410-Q | 2.87M | $102.88 | $295M | $1.6B | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 13, 2026For93.2%
- 2025May 14, 2025For92.0%
- 2024May 15, 2024For87.0%
- 2023May 17, 2023For89.7%
- 2022May 11, 2022For91.3%
- 2021May 13, 2021For92.6%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 13, 2026 | 93.2% | 591M | 43.04M | 3.43M | 63.95M | 8-K |
| 2025May 14, 2025 | 92.0% | 582M | 50.72M | 3.97M | 64.01M | 8-K |
| 2024May 15, 2024 | 87.0% | 561M | 83.46M | 2.60M | 67.83M | 8-K |
| 2023May 17, 2023 | 89.7% | 574M | 65.92M | 3.14M | 71.02M | 8-K |
| 2022May 11, 2022 | 91.3% | 588M | 56.02M | 3.26M | 72.47M | 8-K |
| 2021May 13, 2021 | 92.6% | 607M | 48.28M | 3.24M | 73.79M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XLPState Street(R) Consumer Staples Select Sector SPDR(R) ETFWeight in the fund4.70%
- IYKiShares U.S. Consumer Staples ETFWeight in the fund3.01%
- VDCVanguard Consumer Staples Index FundWeight in the fund2.31%
- FTCSFirst Trust Capital Strength ETFWeight in the fund2.15%
- NOBLProShares S&P 500 Dividend Aristocrats ETFWeight in the fund1.38%
- COWZPacer US Cash Cows 100 ETFWeight in the fund1.16%
- SDYState Street(R) SPDR(R) S&P(R) Dividend ETFWeight in the fund1.16%
- USMViShares MSCI USA Min Vol Factor ETFWeight in the fund0.92%
- SPLVInvesco S&P 500 Low Volatility ETFWeight in the fund0.88%
- SPHQInvesco S&P 500 Quality ETFWeight in the fund0.65%
59 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 1,848
- Q4 2025: Managers 1,894
- Q1 2026: Managers 1,966
- Q2 2026: Managers 2,016
Institutional investors by quarter
The fund managers holding CL, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 2,016 managers held 681M shares, worth $62.4B. During the quarter 189 opened a position, 139 closed one, 702 added and 713 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter-3.8%
- Vanguard Capital ManagementIn the quarter
- State StreetIn the quarter-1.5%
- Price T Rowe AssociatesIn the quarter-17%
- Vanguard Portfolio ManagementIn the quarter+0.8%
- Geode Capital ManagementIn the quarter+1.1%
- Morgan StanleyIn the quarter+5.7%
- First Eagle Investment ManagementIn the quarter+102%
- Bank of New York MellonIn the quarter+8.1%
- Deutsche Bank Ag\In the quarter-1.5%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 69.92M | -3.8% | $6.4B |
| Vanguard Capital Management | 52.25M | $4.8B | |
| State Street | 47.02M | -1.5% | $4.3B |
| Price T Rowe Associates | 27.91M | -17% | $2.6B |
| Vanguard Portfolio Management | 24.02M | +0.8% | $2.2B |
| Geode Capital Management | 23.14M | +1.1% | $2.1B |
| Morgan Stanley | 22.07M | +5.7% | $2.0B |
| First Eagle Investment Management | 16.41M | +102% | $1.5B |
| Bank of New York Mellon | 13.53M | +8.1% | $1.2B |
| Deutsche Bank Ag\ | 11.75M | -1.5% | $1.1B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Colgate-Palmolive's filings show?
Who buys and sells is one part of Colgate-Palmolive's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CL's insiders bought or sold?
From Jun 17, 2026 to Nov 12, 2026 Colgate-Palmolive's insiders bought 0 and sold $38M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold CL?
7 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $427M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.